160 related articles for article (PubMed ID: 37946029)
1. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
[TBL] [Abstract][Full Text] [Related]
2. Circulating CXCL13 could be serving as a biomarker for chronic lymphocytic leukemia severity.
Aref S; Atia D; Ramez A; Zeid TA; Gouda E
Cancer Biomark; 2022; 34(1):105-111. PubMed ID: 34719478
[TBL] [Abstract][Full Text] [Related]
3. CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia.
Sivina M; Xiao L; Kim E; Vaca A; Chen SS; Keating MJ; Ferrajoli A; Estrov Z; Jain N; Wierda WG; Huang X; Chiorazzi N; Burger JA
Leukemia; 2021 Jun; 35(6):1610-1620. PubMed ID: 33087831
[TBL] [Abstract][Full Text] [Related]
4. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia.
Aref S; El Tantawy A; Gouda E; Ayed M
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
[TBL] [Abstract][Full Text] [Related]
7. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 and myeloid-derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia.
Alimu X; Zhang J; Pang N; Zhang R; Chen R; Zeng X; Tudahong S; Chen G; Muhashi M; Zhao F; Ding J; Qu J
Immun Inflamm Dis; 2023 May; 11(5):e853. PubMed ID: 37249287
[TBL] [Abstract][Full Text] [Related]
9. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
Oliveira AC; de la Banda E; Domingo-Domenech E; Encuentra M; Mercadal S; Domingo A; Alonso E; Espinet B; Grau J; De Sevilla AF; Gonzalez-Barca E
Leuk Lymphoma; 2011 Mar; 52(3):429-35. PubMed ID: 21323523
[TBL] [Abstract][Full Text] [Related]
13. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
[TBL] [Abstract][Full Text] [Related]
15. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
Abo Elwafa R; Abd Elrahman A; Ghallab O
Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
Amaya-Chanaga CI; Rassenti LZ
Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
[TBL] [Abstract][Full Text] [Related]
17. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
Del Principe MI; Del Poeta G; Venditti A; Buccisano F; Maurillo L; Marini R; Cox MC; Panetta P; Suppo G; Degan M; Bruno A; Gattei V; Amadori S
Haematologica; 2004 Dec; 89(12):1468-75. PubMed ID: 15590397
[TBL] [Abstract][Full Text] [Related]
19. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
20. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.
De Luca L; D'Arena G; Simeon V; Trino S; Laurenzana I; Caivano A; La Rocca F; Villani O; Mansueto G; Deaglio S; Innocenti I; Laurenti L; Molica S; Pietrantuono G; De Stradis A; Del Vecchio L; Musto P
Leuk Lymphoma; 2017 Jun; 58(6):1424-1432. PubMed ID: 27739922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
